Loading clinical trials...
Loading clinical trials...
A Randomized Controlled Trial of Etoposide in the First-line Treatment of Adult Epstein-barr Virus Associated Hemophagocytic Lymphohistiocytosis
Conditions
Interventions
Etoposide
Dexamethasone
+2 more
Locations
1
China
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Start Date
December 1, 2018
Primary Completion Date
December 1, 2019
Completion Date
December 1, 2020
Last Updated
November 15, 2018
NCT03259230
NCT05841342
NCT01998633
NCT05384743
NCT04077905
NCT01818908
Lead Sponsor
Beijing Friendship Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions